ACTA1 and Hepatic fibrosis: Previous studies have shown that A‐1331852, a pro‐apoptotic BH3 mimetic and Bcl‐xL inhibitor, induces apoptosis in senescent cholangiocytes and α‐SMA‐positive fibroblasts, leading to reduced liver fibrosis in Mdr2−/− mice [17].